|Description||MC 1742 is a novel and selective HDAC inhibitor with potential anticancer activity (IC50= 7, 20, 40, 100, 110 and 610 nM for HDAC6, HDAC3, HDAC10, HDAC1, HDAC2 and HDAC8, respectively). Histone deacetylase inhibitor has been shown to induce growth arrest, apoptosis and differentiation in sarcoma cancer stem cells.|
|Purity||≥98% by HPLC|
|Synonyms||MC-1742; MC 1742; MC1742; 5-[(4-[1,1'-Biphenyl]-4-yl-1,6-dihydro-6-oxo-2-pyrimidinyl)thio]-N-hydroxypentanamide|
|Storage||Store in a cool and dry place (or refer to the Certificate of Analysis).|
MC 1742 is a novel and selective HDAC inhibitor with potential anticancer activity (IC50= 7, 20, 40, 100, 110 and 610 nM for HDAC6, HDAC3, HDAC10, HDAC1, HDAC2 ...
Nexturastat A is an aryl urea derivative that acts as a potent and highly selective inhibitor of histone deacetylase 6 (HDAC6) (IC50= 5.02 +/- 0.60 nM). Nextura...
Sodium butyrate is the sodium salt of butyric acid, used in the culture of mammalian cells.
Valproic acid is an inhibitor of histone deacetylase (HDAC) inhibitor, which has an anticancer effect. It is a branched short-chain fatty acid. It is previously...
CAY10603 is a potent and selective inhibitor of HDAC6 with IC50 of 2 pM, as compared with 271, 252, 0.42, 6851, and 90.7 nM for HDAC1, 2, 3, 8, and 10, respecti...
LMK-235 is a selective histone deacetylase (HDAC) 4 and HDAC5 inhibitor. LMK-235 demonstrates activity against chemoresistant cancer cell lines in an MTT assa...
NSC 3852 is a histone deacetylase inhibitor. It is shown to have cell differentiation and antiproliferative activity in human breast cancer cells.